Immune Checkpoint and Anti-EGFR Regimen Evaluated in Head and Neck Cancer
A retrospective study reports clinical activity and manageable safety for immune checkpoint inhibitors combined with anti-EGFR agents in recurrent or ...
A retrospective study reports clinical activity and manageable safety for immune checkpoint inhibitors combined with anti-EGFR agents in recurrent or ...
A narrative review published in Discover Medicine synthesizes preclinical and clinical evidence regarding the pharmacodynamic interactions between immune checkpoint inhibitors ...
A prospective single-centre cohort study found that half of patients with suspected cardiovascular immune-related adverse events were safely rechallenged with ...
A matched cohort study found immune checkpoint inhibitors did not increase adverse events or worsen survival in cancer patients with ...
A systematic review and network meta-analysis of ten randomized trials evaluated the adverse event profiles of immune checkpoint inhibitor-based combination ...
In a prospective, single-arm, non-randomized phase-Ib/II clinical trial published in Nature Communications, researchers evaluated the safety and activity of extracorporeal ...
A genome-wide CRISPR screen identified the metabolic enzyme GALE as a tumor-intrinsic checkpoint that limits Vγ9Vδ2 T cell-mediated tumor killing ...
A new narrative review maps the rare but potentially fatal cardiovascular toxicities of immune checkpoint inhibitors, from fulminant myocarditis to ...
A comprehensive systematic review and meta-analysis has revealed that low-dose immune checkpoint inhibitors (ICIs) demonstrate comparable efficacy and safety profiles ...
When a cancer patient develops a side effect during immunotherapy, oncologists often see it as a good sign — evidence ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine